These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21632099)

  • 1. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center.
    Bristow RE; Ueda S; Gerardi MA; Ajiboye OB; Ibeanu OA
    Gynecol Oncol; 2011 Aug; 122(2):319-23. PubMed ID: 21632099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
    Dilley S; Erickson BK; Phillips CE; Kennemer CR; Zhang B; Matin T; Martin JY; Shah MM; Michael Straughn J; Leath CA
    Gynecol Oncol; 2018 Apr; 149(1):49-52. PubMed ID: 29605050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in the treatment of advanced epithelial ovarian cancer.
    Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
    Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
    Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
    Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data.
    Terplan M; Schluterman N; McNamara EJ; Tracy JK; Temkin SM
    Gynecol Oncol; 2012 Apr; 125(1):19-24. PubMed ID: 22108636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer.
    Du XL; Sun CC; Milam MR; Bodurka DC; Fang S
    Int J Gynecol Cancer; 2008; 18(4):660-9. PubMed ID: 17892451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Availability of healthcare resources and epithelial ovarian cancer stage of diagnosis and mortality among Blacks and Whites.
    Sakhuja S; Yun H; Pisu M; Akinyemiju T
    J Ovarian Res; 2017 Aug; 10(1):57. PubMed ID: 28830564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unraveling the etiology of ovarian cancer racial disparity in the deep south: Is it nature or nurture?
    Ross J; Braswell KV; Madeira da Silva L; Mujica F; Stutsman S; Finan MA; Nicolson W; Harmon MD; Missanelli M; Cohen A; Singh A; Scalici JM; Rocconi RP
    Gynecol Oncol; 2017 May; 145(2):329-333. PubMed ID: 28215839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease.
    Bristow RE; Chang J; Ziogas A; Randall LM; Anton-Culver H
    Gynecol Oncol; 2014 Feb; 132(2):403-10. PubMed ID: 24361578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. African American women with advanced-stage ovarian cancer have worse outcomes regardless of treatment type.
    Whitmore G; Ramzan A; Sheeder J; Guntupalli SR
    Int J Gynecol Cancer; 2020 Jul; 30(7):1018-1025. PubMed ID: 32107316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database.
    Beckmeyer-Borowko AB; Peterson CE; Brewer KC; Otoo MA; Davis FG; Hoskins KF; Joslin CE
    Cancer Causes Control; 2016 Oct; 27(10):1261-71. PubMed ID: 27590306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study.
    Rungruang BJ; Miller A; Krivak TC; Horowitz NS; Rodriguez N; Hamilton CA; Backes FJ; Carson LF; Friedlander M; Mutch DG; Goodheart MJ; Tewari KS; Wenham RM; Bookman MA; Maxwell GL; Richard SD
    Cancer; 2017 May; 123(6):985-993. PubMed ID: 27864921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of neighborhood socioeconomic status and race on survival from ovarian cancer: a population-based analysis of Cook County, Illinois.
    Brewer KC; Peterson CE; Davis FG; Hoskins K; Pauls H; Joslin CE
    Ann Epidemiol; 2015 Aug; 25(8):556-63. PubMed ID: 25986734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of neighborhood-level socioeconomic status on racial differences in ovarian cancer treatment in a population-based analysis in Chicago.
    Joslin CE; Brewer KC; Davis FG; Hoskins K; Peterson CE; Pauls HA
    Gynecol Oncol; 2014 Nov; 135(2):285-91. PubMed ID: 25173584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.
    Bristow RE; Powell MA; Al-Hammadi N; Chen L; Miller JP; Roland PY; Mutch DG; Cliby WA
    J Natl Cancer Inst; 2013 Jun; 105(11):823-32. PubMed ID: 23539755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of race, socioeconomic status, and the health care system on the treatment of advanced-stage ovarian cancer in California.
    Long B; Chang J; Ziogas A; Tewari KS; Anton-Culver H; Bristow RE
    Am J Obstet Gynecol; 2015 Apr; 212(4):468.e1-9. PubMed ID: 25448522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer.
    Terplan M; Temkin S; Tergas A; Lengyel E
    Gynecol Oncol; 2008 Nov; 111(2):173-8. PubMed ID: 18823649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial Disparities in the Receipt of Guideline Care and Cancer Deaths for Women with Ovarian Cancer.
    Cronin KA; Howlader N; Stevens JL; Trimble EL; Harlan LC; Warren JL
    Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):539-545. PubMed ID: 30487136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial disparities in survival in malignant germ cell tumors of the ovary.
    Hinchcliff E; Rauh-Hain JA; Clemmer JT; Diver E; Hall T; Stall J; Growdon W; Clark R; Schorge J
    Gynecol Oncol; 2016 Mar; 140(3):463-9. PubMed ID: 26773470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer.
    Bian C; Yao K; Li L; Yi T; Zhao X
    Arch Gynecol Obstet; 2016 Jan; 293(1):163-168. PubMed ID: 26198168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.